Browsing by Yonsei Author : Lim, Sun Min

eperson profile image
Name:
Lim, Sun Min [임선민]
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 64

This table browses all dspace content
Issue DateTitleJournal Title
2022Efficacy and safety of atezolizumab, in combination with etoposide and carboplatin regimen, in the first-line treatment of extensive-stage small-cell lung cancer: a single-center experienceCANCER IMMUNOLOGY IMMUNOTHERAPY
2022The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges FRONTIERS IN ONCOLOGY
2022Patritumab Deruxtecan: Paving the Way for EGFR-TKI-Resistant NSCLCCANCER DISCOVERY
2022Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group CANCER RESEARCH AND TREATMENT
2022Predicting treatment outcomes using 18 F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2021Overexpression of poliovirus receptor is associated with poor prognosis in head and neck squamous cell carcinoma patientsJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2021The promise of bispecific antibodies: Clinical applications and challengesCANCER TREATMENT REVIEWS
2021Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma CLINICAL CANCER RESEARCH
2021Clinical decision support algorithm based on machine learning to assess the clinical response to anti-programmed death-1 therapy in patients with non-small-cell lung cancerEUROPEAN JOURNAL OF CANCER
2021A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma CANCER MEDICINE
2021Analyses of CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC from ASTRIS Korean Subset, Open-Label Real-World Study CANCERS
2021Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and Savolitinib JTO Clinical and Research Reports
2021Distinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors CANCERS
2021Sequencing of MET Inhibitors in Lung Cancer: Have We Met the Target?JOURNAL OF THORACIC ONCOLOGY
2021Genomic landscape of extraordinary responses in metastatic breast cancer COMMUNICATIONS BIOLOGY
2021Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma FRONTIERS IN IMMUNOLOGY
2020The Next Target for NSCLC: Let It Be "RET"JOURNAL OF THORACIC ONCOLOGY
2020Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea CANCER RESEARCH AND TREATMENT
2020AXL/MET dual inhibitor, CB469, has activity in non-small cell lung cancer with acquired resistance to EGFR TKI with AXL or MET activationLUNG CANCER
2020Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLCCANCER DISCOVERY
2020Comprehensive analyses of immunodynamics and immunoreactivity in response to treatment in ALK-positive non-small-cell lung cancer JOURNAL FOR IMMUNOTHERAPY OF CANCER
2020Prognostic Value of CD200R1 mRNA Expression in Head and Neck Squamous Cell Carcinoma CANCERS
2020Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer BMC CANCER
2020Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives IMMUNE NETWORK
2017Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.JOURNAL OF CLINICAL ONCOLOGY
2017Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non-Small Cell Lung CancerJOURNAL OF THORACIC ONCOLOGY
2017Rare Incidence of ROS1 Rearrangement in Cholangiocarcinoma CANCER RESEARCH AND TREATMENT
2016Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus ONCOTARGET
2016A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancerCANCER CHEMOTHERAPY AND PHARMACOLOGY
2016ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer modelsLUNG CANCER
2016Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative ONCOTARGET
2016Targeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium) ONCOTARGET
2016Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients. BMC CANCER
2016A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806)LUNG CANCER
2015Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma MOLECULAR CANCER THERAPEUTICS
2015Clinical implications from a single-center study of colorectal adenocarcinoma in transplant recipientsONCOLOGY
2015Lack of ROS1 Gene Rearrangement in Glioblastoma Multiforme PLOS ONE
2015An open label, multicenter, phase II study of dovitinib in advanced thyroid cancerEUROPEAN JOURNAL OF CANCER
2015Association between Obesity Indices and Insulin Resistance among Healthy Korean Adolescents: The JS High School Study PLOS ONE
2015Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children CANCER RESEARCH AND TREATMENT
2014Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements PLOS ONE
2014A Single-Tube Multiplexed Assay for Detecting ALK, ROS1, and RET Fusions in Lung CancerJOURNAL OF MOLECULAR DIAGNOSTICS
2014Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinomaLUNG CANCER
2014Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinomaLUNG CANCER
2014Targeted therapy in gastric cancer: Personalizing cancer treatment based on patient genome WORLD JOURNAL OF GASTROENTEROLOGY
2014Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation studyJOURNAL OF CLINICAL PATHOLOGY
2013A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypesANNALS OF ONCOLOGY
2013Psychosocial Impact of Cancer Patients on Their Family Members CANCER RESEARCH AND TREATMENT
2013Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patientsCANCER CHEMOTHERAPY AND PHARMACOLOGY
2013Combination of CYP inhibitor with MEK/ERK inhibitor enhances the inhibitory effect on ERK in BRAF mutant colon cancer cells.ANTICANCER RESEARCH
12

Browse

Links